DE-71-induced apoptosis involving intracellular calcium and the Bax-mitochondria-caspase protease pathway in human neuroblastoma cells in vitro

Toxicol Sci. 2008 Aug;104(2):341-51. doi: 10.1093/toxsci/kfn088. Epub 2008 May 2.

Abstract

Polybrominated diphenyl ethers (PBDEs) are used extensively as flame-retardants and are ubiquitous in the environment and in wildlife and human tissue. Recent studies have shown that PBDEs induce neurotoxic effects in vivo and apoptosis in vitro. However, the signaling mechanisms responsible for these events are still unclear. In this study, we investigated the action of a commercial mixture of PBDEs (pentabrominated diphenyl ether, DE-71) on a human neuroblastoma cell line, SK-N-SH. A cell viability test showed a dose-dependent increase in lactate dehydrogenase leakage and 3-(4,5-dimethylthia-zol-2-yl)-2,5-diphenyl-tetrazolium bromide reduction. Cell apoptosis was observed through morphological examination, and DNA degradation in the cell cycle and cell apoptosis were demonstrated using flow cytometry and DNA laddering. The formation of reactive oxygen species was not observed, but DE-71 was found to significantly induce caspase-3, -8, and -9 activity, which suggests that apoptosis is not induced by oxidative stress but via a caspase-dependent pathway. We further investigated the intracellular calcium ([Ca(2+)](i)) levels using flow cytometry and observed an increase in the intracellular Ca(2+) concentration with a time-dependent trend. We also found that the N-methyl d-aspartate (NMDA) receptor antagonist MK801 (3 microM) significantly reduced DE-71-induced cell apoptosis. The results of a Western blotting test demonstrated that DE-71 treatment increases the level of Bax translocation to the mitochondria in a dose-dependent fashion and stimulates the release of cytochrome c (Cyt c) from the mitochondria into the cytoplasm. Overall, our results indicate that DE-71 induces the apoptosis of [Ca(2+)](i) in SK-N-SH cells via Bax insertion, Cyt c release in the mitochondria, and the caspase activation pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / drug effects*
  • Calcium / metabolism*
  • Caspases / biosynthesis*
  • Cell Line, Tumor / drug effects
  • Cell Survival / drug effects
  • Cytochromes c / metabolism
  • DNA Damage
  • DNA, Neoplasm / drug effects
  • Dizocilpine Maleate / pharmacology
  • Dose-Response Relationship, Drug
  • Enzyme Induction
  • Flame Retardants / toxicity
  • Halogenated Diphenyl Ethers
  • Humans
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Neuroblastoma / drug therapy*
  • Neuroblastoma / metabolism
  • Phenyl Ethers / toxicity*
  • Polybrominated Biphenyls / toxicity*
  • Reactive Oxygen Species / metabolism
  • bcl-2-Associated X Protein / metabolism*

Substances

  • BAX protein, human
  • DNA, Neoplasm
  • Flame Retardants
  • Halogenated Diphenyl Ethers
  • Phenyl Ethers
  • Polybrominated Biphenyls
  • Reactive Oxygen Species
  • bcl-2-Associated X Protein
  • Dizocilpine Maleate
  • pentabromodiphenyl ether
  • Cytochromes c
  • Caspases
  • Calcium